The European Medicines Agency’s Committee for Medicinal Products for Human Use previously issued a positive opinion ...
NEXSPIKE is Moderna’s third product to receive a positive CHMP opinion alongside Spikevax (COVID-19 Vaccine, mRNA) and ...
A rapid, two-step immune reaction may underlie rare cases of heart inflammation seen after COVID-19 mRNA vaccination, ...
A recent study has provided the first side-by-side comparison of how three major COVID-19 vaccine types differ in triggering ...
13don MSN
Vaccine stocks slide as FDA official links COVID vaccines and heart conditions in young men
Concern about that link, particularly relating to teenage boys and young men, has been a key argument against administering ...
CAMBRIDGE, MA / ACCESS Newswire / September 16, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced positive preliminary immunogenicity data for the 2025-2026 formula of Spikevax®, which targets the LP ...
The U.S. Food and Drug Administration has no plans to put a "black box" warning on COVID-19 vaccines, Bloomberg News reported ...
The U.S. Food and Drug Administration (FDA) has no plans to place a black box warningthe most serious safety labelon COVID-19 ...
The U.S. Food and Drug Administration (FDA) is considering adding the strongest safety warning available to COVID-19 vaccines ...
The US Food and Drug Administration intends to put a “black box” warning on Covid-19 vaccines, according to two people familiar with the agency’s plans.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback